Robert Z. Orlowski, Meletios A. Dimopoulos, Xavier Leleu, Thierry Facon, Tadao Ishida, Roman Hajek, Ivan Špička, Joanna Romejko-Jarosińska, Vladimir Vorobyev, Britta Besemer, Sevgi Kalayoğlu Beşışık, Pawel Robak, Tomas Jelinek, Hartmut Goldschmidt, Thomas Martin, Mohamad Mohty, Sandrine Macé, Ercem Kodas, Christina Tekle, Andrea T. Shafer, Philippe Moreau. "Isatuximab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma: dynamics of MRD negativity in the IMROZ study." Blood, 2026. doi:10.1182/blood.2025030120